What is the most common bacterial pathogen causing infective endocarditis?

Most Common Bacteria in Infective Endocarditis

Staphylococcus aureus is now the most common bacterial pathogen causing infective endocarditis, having overtaken viridans group streptococci in recent years. 1, 2

Epidemiological Shift in IE Pathogens

The microbiology of infective endocarditis has undergone a significant transformation over the past two decades. While viridans group streptococci historically dominated as the causative organism, the epidemiology has definitively shifted to Staphylococcus aureus as the predominant pathogen 1, 2. This transition reflects changes in at-risk populations, including increased intravenous drug use, healthcare-associated infections, and intracardiac device implantations 1, 2.

Current Pathogen Distribution

Based on the most recent evidence, the bacterial causes of IE rank as follows:

Primary Pathogens:

• Staphylococcus species (33%) - most common overall 3
  • Methicillin-sensitive S. aureus (MSSA) - showing increasing incidence over time 3
  • Methicillin-resistant S. aureus (MRSA) - associated with significantly higher mortality 3
  • Coagulase-negative staphylococci - decreasing incidence 3

Secondary Pathogens:

• Streptococcus species (26%) - including viridans group streptococci 3

  • Decreasing incidence over time 3
  • Still important in subacute presentations 4

• Enterococcus species (17%) 3

  • Primarily E. faecalis (90% of enterococcal cases) 5
  • Associated with treatment complications and worse outcomes 2

Clinical Implications by Pathogen

Staphylococcus aureus IE:

S. aureus causes acute, destructive endocarditis with rapid clinical deterioration 5. Despite producing more extensive intracardiac lesions, patients with staphylococcal IE who receive timely surgical intervention demonstrate better functional outcomes 6. The 2015 ESC guidelines emphasize that S. aureus IE is "usually responsible for acute and destructive IE" 5, contrasting sharply with the historical "subacute bacterial endocarditis" terminology that characterized streptococcal disease 2.

Streptococcal IE:

Viridans group streptococci produce more indolent infections with a protracted clinical course extending weeks to months 2. The subacute presentation allows for different empirical coverage strategies 4.

Important Caveat - Temporal Trends:

The incidence of MSSA infections is increasing over time, while coagulase-negative staphylococci and streptococci infections are decreasing 3. MRSA infection carries particularly poor prognosis with a hazard ratio of 2.56 compared to streptococcal infection 3.

Empirical Coverage Recommendations

The 2015 AHA guidelines provide pathogen-specific empirical coverage based on clinical presentation 4:

For acute presentations (days):

• Cover S. aureus, β-hemolytic streptococci, and aerobic Gram-negative bacilli 4

For subacute presentations (weeks):

• Cover S. aureus, viridans group streptococci, HACEK organisms, and enterococci 4

For prosthetic valve IE <1 year post-surgery:

• Cover staphylococci, enterococci, and aerobic Gram-negative bacilli 4

For prosthetic valve IE >1 year post-surgery:

• Cover staphylococci, viridans group streptococci, and enterococci 4

Key Clinical Pitfall

Do not assume streptococci remain the dominant pathogen based on older teaching. The shift to staphylococcal predominance fundamentally changes the clinical approach, requiring heightened vigilance for acute presentations, aggressive source control consideration, and recognition that the classic "subacute bacterial endocarditis" terminology no longer reflects the majority of contemporary IE cases 2.